🔴 Aspire BioPharma is trading 5% down today — no separate catalyst confirmed

Aspire BioPharma is trading 5% down now at $7.33; no separate catalyst explaining the decline has been confirmed.

• On August 10, 2026, the company announced completion of its approximately $30 million cash acquisition of Dura Driver Control Systems.
• The announcement also said Aspire BioPharma entered a $22.5 million secured revolving credit facility.
• The announcement did not explicitly connect either transaction to the intraday decline.